PubMed Health⌕ Search

PubMed · 8318433

Phenofibrate-induced lichenoid photodermatitis.

Abstract

Phenofibrate is an hypolipemiant drug derived from fibric acid. Cutaneous side effects such as pruritus, rash, urticarial lesions and some rare cases of photosensitivity have been described (1-3). The reported photosensitivity cases are clinically described as eczematous (1-3); some have been reproduced by photopatch-testing (2, 3). We studied a patient with a clinical and histopathological lichenoid eruption over light-exposed areas clearly related to phenofibrate therapy for an essential hypercholesterolemia.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J Gardeazabal, M Gonzalez, R Izu, N Gil, A Aguirre, J L Diaz-Perez. 1993. Phenofibrate-induced lichenoid photodermatitis.. https://pubmed.ncbi.nlm.nih.gov/8318433/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[The red face].

Facial erythema may not only present clinically as a distinct entity, but can also be a symptom of other diseases. It is seen in common dermatoses such as eczema, psoriasis, acne and urticaria, as well as in rarer conditions such as disorders of keratinization, infectious diseases, porphyrias and neoplasia. Facial erythema may also present as a symptom of carcinoid syndrome, drug allergies, cardiac disease or in rare cases as a feature of Bloom's syndrome, sarcoidosis, lymphoma, amyloidosis and other disease processes. We would like to concentrate on the practical aspects of facial erythema as a presenting symptom, rather than discussing every disease in detail.

Dermatitis, Photoallergic↗